Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.

[1]  A. Goette,et al.  Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo. , 2013, International journal of cardiology.

[2]  E. Loh,et al.  Dosage of statin, cardiovascular comorbidities, and risk of atrial fibrillation: a nationwide population-based cohort study. , 2013, International journal of cardiology.

[3]  Ying H. Shen,et al.  PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1. , 2013, European journal of pharmacology.

[4]  U. Schotten,et al.  Dynamic remodeling of intracellular Ca²⁺ signaling during atrial fibrillation. , 2013, Journal of molecular and cellular cardiology.

[5]  S. Yusuf,et al.  Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. , 2013, International journal of cardiology.

[6]  E. Schiffrin,et al.  Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. , 2013, Cardiovascular research.

[7]  Li Zhou,et al.  Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. , 2012, Experimental cell research.

[8]  Xiaoming Pang,et al.  Rosiglitazone inhibits angiotensin II-induced C-reactive protein production in human aortic endothelial cells through regulating AT1–ROS–MAPK signal pathway , 2012, Inflammation Research.

[9]  T. Chao,et al.  Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes. , 2012, International journal of cardiology.

[10]  S. Niwano,et al.  Angiotensin II-mediated up-regulation of connective tissue growth factor promotes atrial tissue fibrosis in the canine atrial fibrillation model , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  K. Aonuma,et al.  PPAR‐γ Activator Pioglitazone Prevents Age‐Related Atrial Fibrillation Susceptibility by Improving Antioxidant Capacity and Reducing Apoptosis in a Rat Model , 2012, Journal of cardiovascular electrophysiology.

[12]  Stanley Nattel,et al.  Atrial fibrillation pathophysiology: implications for management. , 2011, Circulation.

[13]  M. Gheorghiade,et al.  n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion: A Prospective, Randomized Study , 2011, Circulation.

[14]  Wei-feng Jiang,et al.  Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  Niels Voigt,et al.  Recent advances in the molecular pathophysiology of atrial fibrillation. , 2011, The Journal of clinical investigation.

[16]  L. Lai,et al.  Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor β1. , 2011, Cardiovascular research.

[17]  Shenming Wang,et al.  Atrial Fibrillation Induces Myocardial Fibrosis Through Angiotensin II Type 1 Receptor–Specific Arkadia-Mediated Downregulation of Smad7 , 2011, Circulation research.

[18]  H. Yoshimatsu,et al.  Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. , 2010, Heart rhythm.

[19]  Songbin Fu,et al.  TAK1 lysine 158 is required for TGF-β-induced TRAF6-mediated Smad-independent IKK/NF-κB and JNK/AP-1 activation. , 2011, Cellular signalling.

[20]  Shih‐Ann Chen,et al.  Extracellular matrix of collagen modulates intracellular calcium handling and electrophysiological characteristics of HL-1 cardiomyocytes with activation of angiotensin II type 1 receptor. , 2011, Journal of cardiac failure.

[21]  L. Lai,et al.  Angiotensin II induces complex fractionated electrogram in a cultured atrial myocyte monolayer mediated by calcium and sodium-calcium exchanger. , 2011, Cell calcium.

[22]  H. Pan,et al.  Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix production , 2011, Molecular Biology Reports.

[23]  J. Golledge,et al.  Pioglitazone-Induced Reductions in Atherosclerosis Occur via Smooth Muscle Cell–Specific Interaction With PPAR&ggr; , 2010, Circulation research.

[24]  A. Saiki,et al.  Pioglitazone decreases plasma angiotensin II concentration in type 2 diabetes. , 2010, Journal of atherosclerosis and thrombosis.

[25]  R. de Caterina,et al.  PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. , 2010, Cardiovascular research.

[26]  Markus Grube,et al.  Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. , 2010, Journal of the American College of Cardiology.

[27]  N. Alenina,et al.  Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload , 2009, PloS one.

[28]  C. Desouza,et al.  Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells. , 2009, Vascular pharmacology.

[29]  Y. On,et al.  Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. , 2009, The Journal of thoracic and cardiovascular surgery.

[30]  Yong-ling Wang,et al.  Down-regulation of the expression of angiotensin II type 1 receptor in neonatal rat cardiac fibroblast by activation of PPARgamma signal pathway. , 2008, The Chinese journal of physiology.

[31]  Stanley Nattel,et al.  Calcium-Handling Abnormalities Underlying Atrial Arrhythmogenesis and Contractile Dysfunction in Dogs With Congestive Heart Failure , 2008, Circulation. Arrhythmia and electrophysiology.

[32]  X. Niu,et al.  Agonists at PPAR‐γ suppress angiotensin II‐induced production of plasminogen activator inhibitor‐1 and extracellular matrix in rat cardiac fibroblasts , 2008, British journal of pharmacology.

[33]  S. Nattel,et al.  Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure. , 2008, Heart rhythm.

[34]  L. Lai,et al.  Renin–angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation , 2008, Journal of hypertension.

[35]  L. Lai,et al.  Angiotensin II Increases Expression of α1C Subunit of L-Type Calcium Channel Through a Reactive Oxygen Species and cAMP Response Element–Binding Protein–Dependent Pathway in HL-1 Myocytes , 2007 .

[36]  K. Sunagawa,et al.  Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma. , 2006, Cardiovascular research.

[37]  Sang -Geon Kim,et al.  Peroxisome Proliferator-Activated Receptor-γ and Retinoic Acid X Receptor α Represses the TGFβ1 Gene via PTEN-Mediated p70 Ribosomal S6 Kinase-1 Inhibition: Role for Zf9 Dephosphorylation , 2006, Molecular Pharmacology.

[38]  J. Roman,et al.  Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[39]  M. Capecchi,et al.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. , 2004, The American journal of pathology.

[40]  Sander Verheule,et al.  Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.

[41]  A. Ducharme,et al.  Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials , 2003, Circulation.

[42]  E. Robertis,et al.  Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β , 2002, Nature Cell Biology.

[43]  R F Bosch,et al.  Ionic mechanisms of electrical remodeling in human atrial fibrillation. , 1999, Cardiovascular research.